Avoro Capital Advisors LLC Q1 2016 Filing

Filed May 16, 2016

Portfolio Value

$286.7B

Holdings

36

Report Date

Q1 2016

Filing Type

13F-HR

All Holdings (36 positions)

#StockSharesValue% PortfolioType
1
MRTXEURMIRATI THERAPEUTICS INC.
1,404,055$30.0B10.48%
2
AM6AMICUS THERAPEUTICS INC
3,424,104$28.9B10.09%
3
SRPTSAREPTA THERAPEUTICS -INC
1,462,500$24.6B8.57%Call
4
BMRNBIOMARIN PHARMACEUTICAL INC
277,272$22.9B7.98%
5
GILDGILEAD SCIENCES INC
175,400$16.1B5.62%
6
NBIXNEUROCRINE BIOSCIENCES INC
405,320$16.0B5.59%
7
LION BIOTECHNOLOGIES INC
3,125,198$15.9B5.54%
8
CELATOR PHARMACEUTICALS INC.
1,416,257$15.6B5.45%
9
MEDIVATION INC
270,665$12.4B4.34%
10
BMYBRISTOL MYERS SQUIBB CO.
175,000$11.2B3.90%
11
AGENEURAGENUS - INC
2,400,868$10.0B3.48%
12
ANACOR PHARMACEUTICALS INC
166,700$8.9B3.11%
13
NEURODERM LTD.
537,477$7.6B2.65%
14
VNDAVANDA PHARMACEUTICALS INC
854,579$7.1B2.49%
15
TESARO INC.
150,000$6.6B2.30%
16
SRNESORRENTO THERAPEUTICS INC
1,145,779$6.2B2.15%
17
ONCOTHYREON INC
4,069,072$5.2B1.80%
18
TELIGENT INC.
925,000$4.5B1.58%
19
LA JOLLA PHARMACEUTICAL CO.
211,672$4.4B1.54%
20
FORTRESS BIOTECH INC.
1,337,869$4.1B1.45%
21
PERNIX THERAPEUTICS HOLDINGS
3,889,900$4.1B1.42%
22
VCYTVERACYTE INC
730,514$3.9B1.38%
23
DERMIRA INC
175,000$3.6B1.26%
24
GBTUSDGLOBAL BLOOD THERAPEEUTICS INC
208,086$3.3B1.15%
25
IMMUNOMEDICS INC
1,050,457$2.6B0.92%
26
TREURTRILLIUM THERAPEUTICS INC
228,697$2.1B0.74%
27
VCELVERICEL CORP.
275,000$1.6B0.56%
28
NANTKWEST- INC
194,912$1.6B0.56%
29
EGALET CORPORATION.
233,334$1.6B0.56%
30
AEGERION PHARMACEUTICALS INC
306,800$1.1B0.40%
31
CRVSCORVUS PHARMACEUTICALS INC
74,800$1.1B0.38%
32
CLLSCELLECTIS - ADR
25,000$688.0M0.24%
33
LVLNSPDR SERIES TRUST - S&P BIOTECH
750,000$670.0M0.23%Put
34
CATALYST BIOSCIENCES INC.
71,500$120.0M0.04%
35
INTREXON CORP.
200,000$60.0M0.02%Call
36
AQLTISHARES RUSSELL 2000 ETF
250,000$51.0M0.02%Put